AEMD أخبار الفوركس
Aethlon Inks Materials Transfer Deal For Santersus' NucleoCapture And HemoNucleoCapture Devices
Medical therapeutic company Aethlon Medical, Inc. (AEMD) announced Wednesday that it entered into a Materials Transfer Agreement (MTA) with Santersus AG, a Zurich-London based, privately held therapeutic medical device company, for Santersus' NucleoCapture and HemoNucleoCapture devices.
RTTNews
|
953 منذ أيام
